CompPharma Reports Progress on Opioids, Compounds

Three years ago, workers’ comp payers cited three key drivers to drug spend: opioids, physician-dispensed drugs and compounded medications. Now, the latest edition of an annual report from CompPharma shows that progress has been made on at least two of those issues. The CompPharma report found that opioid spending was down 13.3% in 2016. And use of compounds plummeted 40%. Overall, drug spending was down 11% in 2016. That brings the total decrease in drug spend to 22% over the last seven years, according to CompPharma, a consortium of workers’ comp pharmacy benefit managers that ...